malondialdehyde has been researched along with Bile Duct Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dayangac, M; Ersin, S; Firat, O; Gulter, C; Makay, O; Mutaf, I; Sari, M; Tuncyurek, P; Tunger, A; Yilmaz, M; Yuce, G | 1 |
| Ghazi-Khansari, M; Ghobadi, G; Karimian, G; Mohammadi-Karakani, A; Shakiba, B; Sotoudeh, M | 1 |
2 other study(ies) available for malondialdehyde and Bile Duct Diseases
| Article | Year |
|---|---|
Does pharmaconutrition with L-arginine and/or alpha-tocopherol improve the gut barrier in bile duct ligated rats?
Topics: Administration, Oral; alpha-Tocopherol; Animals; Arginine; Bacterial Translocation; Bile Duct Diseases; Bile Ducts; Dietary Supplements; Liver Cirrhosis, Experimental; Male; Malondialdehyde; Rats; Rats, Wistar | 2006 |
Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Bile Duct Diseases; Captopril; Common Bile Duct; Constriction, Pathologic; Enalapril; Glutathione; Hydroxyproline; Ligation; Liver; Liver Cirrhosis; Male; Malondialdehyde; Rats; Rats, Wistar | 2008 |